Strong antitumor activities of IgG3 antibodies to a human melanoma-associated ganglioside
- PMID: 3856277
- PMCID: PMC397290
- DOI: 10.1073/pnas.82.5.1499
Strong antitumor activities of IgG3 antibodies to a human melanoma-associated ganglioside
Abstract
Three mouse monoclonal IgG3 antibodies, 2B2, IF4, and MG-21, recognize a GD3 ganglioside antigen that is expressed at the cell surface of most human melanomas. All three antibodies mediate antibody-dependent cellular cytotoxicity (ADCC) in vitro when tested with human lymphocytes as effector cells in a 2-hr or 4-hr 51Cr-release test, and one antibody, MG-21, also gives strong complement-dependent cytotoxicity with human serum. Antibody 2B2, which gives ADCC also in the presence of mouse lymphocytes, inhibited the outgrowth of a human melanoma in nude mice, but antibody IF4, which showed no ADCC with mouse lymphocyte effectors, did not.
Similar articles
-
Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis.Proc Natl Acad Sci U S A. 1985 Aug;82(15):5155-9. doi: 10.1073/pnas.82.15.5155. Proc Natl Acad Sci U S A. 1985. PMID: 3860849 Free PMC article.
-
Immune and nonimmune effector functions of IgG3 mouse monoclonal antibody R24 detecting the disialoganglioside GD3 on the surface of melanoma cells.Clin Immunol Immunopathol. 1987 Nov;45(2):214-29. doi: 10.1016/0090-1229(87)90036-5. Clin Immunol Immunopathol. 1987. PMID: 3665201
-
Light chain variants of an IgG3 anti-GD3 monoclonal antibody and the relationship among avidity, effector functions, tumor targeting, and antitumor activity.Cancer Res. 1990 Mar 1;50(5):1503-9. Cancer Res. 1990. PMID: 2105840
-
Anti-melanoma effects of R24, a monoclonal antibody against GD3 ganglioside.Melanoma Res. 1997 Aug;7 Suppl 2:S155-62. Melanoma Res. 1997. PMID: 9578432 Review.
-
Native and genetically engineered anti-disialoganglioside monoclonal antibody treatment of melanoma.Cancer Chemother Biol Response Modif. 2005;22:789-97. doi: 10.1016/s0921-4410(04)22037-3. Cancer Chemother Biol Response Modif. 2005. PMID: 16110641 Review. No abstract available.
Cited by
-
Chimeric mouse-human IgG1 antibody that can mediate lysis of cancer cells.Proc Natl Acad Sci U S A. 1987 May;84(10):3439-43. doi: 10.1073/pnas.84.10.3439. Proc Natl Acad Sci U S A. 1987. PMID: 3106970 Free PMC article.
-
GD3 expression by cultured human tumor cells of neuroectodermal origin.Acta Neuropathol. 1989;79(3):317-25. doi: 10.1007/BF00294668. Acta Neuropathol. 1989. PMID: 2609939
-
Use of antibodies and immunoconjugates for the therapy of more accessible cancers.Adv Drug Deliv Rev. 2008 Sep;60(12):1407-20. doi: 10.1016/j.addr.2008.04.011. Epub 2008 Apr 24. Adv Drug Deliv Rev. 2008. PMID: 18508155 Free PMC article. Review.
-
Secretion of functional antibody and Fab fragment from yeast cells.Proc Natl Acad Sci U S A. 1988 Nov;85(22):8678-82. doi: 10.1073/pnas.85.22.8678. Proc Natl Acad Sci U S A. 1988. PMID: 3054890 Free PMC article.
-
Differential effects of synthetic sphingosine derivatives on melanoma cell motility, growth, adhesion and invasion in vitro.Clin Exp Metastasis. 1996 Nov;14(6):477-89. doi: 10.1007/BF00115108. Clin Exp Metastasis. 1996. PMID: 8970578
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical